Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 8,400 | 9,543 | 12,669 | 9,163 | 7,694 |
| Operating Income | -8,400 | -9,543 | -12,669 | -9,163 | -7,694 |
| Other Income | 2 | 1 | 2 | 0 | 370 |
| Pre-tax Income | -8,399 | -9,542 | -12,667 | -9,163 | -7,324 |
| Net Income Continuous | -8,399 | -9,542 | -12,667 | -9,163 | -7,324 |
| Net Income | $-8,399 | $-9,542 | $-12,667 | $-9,163 | $-7,324 |
| EPS Basic Total Ops | -1.20 | -1.32 | -2.16 | -2.16 | -1.92 |
| EPS Basic Continuous Ops | -1.20 | -1.29 | -2.15 | -2.18 | -1.98 |
| EPS Diluted Total Ops | -1.20 | -1.32 | -2.16 | -2.16 | -1.92 |
| EPS Diluted Continuous Ops | -1.20 | -1.29 | -2.15 | -2.18 | -1.98 |
| EBITDA(a) | $-8,395 | $-9,536 | $-12,663 | $-9,156 | $-7,687 |